pharma · Advanced Solid Tumor · Hepatocellular Carcinoma
Coherus Oncology
Coherus Oncology clinical programs — 11 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 333 Twin Dolphin Drive, Suite 600, Redwood City, CA 94065, US
- Founded
- 2010
- Employees
- 212
- Programs
- 25
- Drugs
- 11
- Patents
- 73
Coherus Oncology projects
11 ClinicalTrials.gov programs sponsored by Coherus Oncology.
Coherus Oncology has 11 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Casdozokitug
Coherus Oncology
Hepatocellular Carcinoma
1 trial -
Dupilumab
Coherus Oncology
Metastatic Colorectal Cancer
1 trial -
NY-ESO-1 Peptide vaccine
Coherus Oncology
Ovarian Cancer Stage IV
1 trial -
Nadunolimab
Coherus Oncology
Metastatic Microsatellite Stable Colorectal Carcinoma
1 trial -
SRF388
Coherus Oncology
Hepatocellular Carcinoma
1 trial -
STC-15 in combination with toripalimab
Coherus Oncology
Solid Tumor
1 trial -
Toripalimab
Coherus Oncology
Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
1 trial -
Toripalimab
Coherus Oncology
Localized Colon Carcinoma
1 trial -
Toripalimab
Coherus Oncology
Sinonasal Cancer
1 trial -
Toripalimab + Chemotherapy
Coherus Oncology
Head and Neck Cancer
1 trial -
Toripalimab-tpzi
Coherus Oncology
Squamous Cell Carcinoma
1 trial
Frequently asked questions
How many clinical projects does Coherus Oncology have?
11 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.